Avenacy Ushers in New Era of Diuretic Therapy with Furosemide Injection Launch in the U.S.
Avenacy LLC, a specialty pharmaceutical company, announced the release of Furosemide for Injection, a diuretic for edema from heart failure, liver, and kidney diseases, in the U.S. This aims to enhance patient care with its unique packaging and is anticipated by the healthcare industry.
Read More